Division of Pharmacology, Department of Neuroscience, Psychology, Drug Sciences and Child Health (NeuroFarBa), University of Florence, 50139 Firenze, Italy.
Cells. 2021 Oct 18;10(10):2789. doi: 10.3390/cells10102789.
Life-threatening ventricular arrhythmias are the main clinical burden in patients with hypertrophic cardiomyopathy (HCM), and frequently occur in young patients with mild structural disease. While massive hypertrophy, fibrosis and microvascular ischemia are the main mechanisms underlying sustained reentry-based ventricular arrhythmias in advanced HCM, cardiomyocyte-based functional arrhythmogenic mechanisms are likely prevalent at earlier stages of the disease. In this review, we will describe studies conducted in human surgical samples from HCM patients, transgenic animal models and human cultured cell lines derived from induced pluripotent stem cells. Current pieces of evidence concur to attribute the increased risk of ventricular arrhythmias in early HCM to different cellular mechanisms. The increase of late sodium current and L-type calcium current is an early observation in HCM, which follows post-translation channel modifications and increases the occurrence of early and delayed afterdepolarizations. Increased myofilament Ca sensitivity, commonly observed in HCM, may promote afterdepolarizations and reentry arrhythmias with direct mechanisms. Decrease of K-currents due to transcriptional regulation occurs in the advanced disease and contributes to reducing the repolarization-reserve and increasing the early afterdepolarizations (EADs). The presented evidence supports the idea that patients with early-stage HCM should be considered and managed as subjects with an acquired channelopathy rather than with a structural cardiac disease.
危及生命的室性心律失常是肥厚型心肌病(HCM)患者的主要临床负担,并且经常发生在轻度结构性疾病的年轻患者中。虽然巨大肥厚、纤维化和微血管缺血是晚期 HCM 中基于持续折返的室性心律失常的主要机制,但基于心肌细胞的功能性心律失常机制可能在疾病的早期更为普遍。在这篇综述中,我们将描述在 HCM 患者的外科手术样本、转基因动物模型和源自诱导多能干细胞的人类培养细胞系中进行的研究。目前的证据一致认为,早期 HCM 中室性心律失常风险的增加归因于不同的细胞机制。晚期钠电流和 L 型钙电流的增加是 HCM 的早期观察结果,这是在翻译后通道修饰之后发生的,并增加了早期和延迟后除极的发生。在 HCM 中常见的肌球蛋白钙敏感性增加可能通过直接机制促进后除极和折返性心律失常。由于转录调节而导致的 K 电流减少发生在晚期疾病中,并有助于减少复极储备并增加早期后除极(EAD)。所提供的证据支持这样一种观点,即应将早期 HCM 患者视为具有获得性通道病的患者,而不是具有结构性心脏病的患者进行考虑和管理。